Previous issues
-
Previous issues
Volume 26(2) Apr 2020
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Guideline KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
- Clin Mol Hepatol. 2020;26(2):83-127.
- Reviews Application of transient elastography in nonalcoholic fatty liver disease
- Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
- Clin Mol Hepatol. 2020;26(2):128-141.
- Drug induced liver injury: East versus West – a systematic review and meta-analysis
- En Xian Sarah Low, Qishi Zheng, Edwin Chan, Seng Gee Lim
- Clin Mol Hepatol. 2020;26(2):142-154.
- Switching to systemic therapy after locoregional treatment failure: Definition and best timing
- Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato
- Clin Mol Hepatol. 2020;26(2):155-162.
- Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source
- Feng Chen, Hua Wang, Jia Xiao
- Clin Mol Hepatol. 2020;26(2):163-179.
- Editorials Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
- Hyun Woong Lee
- Clin Mol Hepatol. 2020;26(2):180-182.
- Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
- Ju Hyun Shim
- Clin Mol Hepatol. 2020;26(2):183-184.
- Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
- Soung Won Jeong
- Clin Mol Hepatol. 2020;26(2):185-186.
- Original Articles The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?
- Sujata Lall, Pragya Agarwala, Guresh Kumar, Manoj Kumar Sharma, Ekta Gupta
- Clin Mol Hepatol. 2020;26(2):187-195.
- Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
- Rahul Kumar, Boon-Bee George Goh, Jia-Wen Kam, Pik-Eu Chang, Chee-Kiat Tan
- Clin Mol Hepatol. 2020;26(2):196-208.
- Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
- Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim
- Clin Mol Hepatol. 2020;26(2):209-215.
- Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
- Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky
- Clin Mol Hepatol. 2020;26(2):216-226.
- Letters to the Editor Multimodal sequential treatment for occluded TIPS: Case report and review of literature
- Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele
- Clin Mol Hepatol. 2020;26(2):227-230.
- Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
- Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado
- Clin Mol Hepatol. 2020;26(2):231-232.
- A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
- Yang-Hyun Baek
- Clin Mol Hepatol. 2020;26(2):233-235.
- Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
- Hyuk Soo Eun
- Clin Mol Hepatol. 2020;26(2):236-237.
- Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma
- Hwi Young Kim, Jean-François Dufour
- Clin Mol Hepatol. 2020;26(2):238-239.
- Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
- Jung Hwan Yu
- Clin Mol Hepatol. 2020;26(2):240-241.